rHuEPO plays a central role as chemicals for the treatment of many diseases. Due to its
short half‐life, the main aim for this pharmacokinetic study is to investigate a newly …

A method based on CZE for the determination of glutamic acid, glycine, and alanine in a
biopharmaceutical formulation containing recombinant human erythropoietin was …

The majority of Jehovah's Witnesses refuse blood product transfusion, even when it can be
lifesaving. Treatment with recombinant human erythropoietin (RHuEPO) is a valuable …

Jehovah's Witnesses undergoing liver or pancreas surgery represent a unique medical and
ethical challenge. For hepatic and pancreatic malignancies, resections are currently the only …

Recombinant protein aggregation is a problematic issue and can provoke immunological
response. The aim of this study was to analyze the stability of erythropoietin (EPO), as a …

Purpose This is the first cross-sectional study studying the changes in haematological
indicators of the response to recombinant human erythropoietin (rHuEPO) therapy in chronic …

Intravenous (IV) iron and Erythropoiesis Stimulating Agents (ESAs) are recommended for
anemia management in chronic kidney disease (CKD). This retrospective cohort study …

Erythropoietin (EPO), an essential hormone for erythropoiesis, can provide protection
against myocardial ischemia/reperfusion (I/R) injury and hypoxic apoptosis. GATA-4 is a zinc …

CLINICAL PATHOLOGY AND MEDICAL LABORATORY Page 1 Vol. 14. No. 1 November
2007 ISSN 0854-4263 INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND …

Background: Iron is an essential micronutrient which plays a significant role, particularly vital
for early brain growth and function. Maternal iron condition influences the iron status of …